Humonix Biosciences is a specialty pharma research company that uses an innovative human tissue engineering platform technology to reduce the cost of drug development. Humonix collaborates with industry and academic partners to help screen for and identify lead candidates, elucidate their MOA and validate their efficacy. Humonix's 3D tissue technology can reduce the risk of clinical trial failure while saving time, labor and development costs. Early identification and validation of effective compounds or biologics allows our partners to confidently enter clinical trials.
Location: United States, New York, City of Albany
Employees: 11-50
Founded date: 2015